Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity

被引:11
|
作者
Liao, Weike [1 ]
Wang, Zhongyuan [2 ]
Han, Yufei [3 ]
Qi, Yinliang [3 ]
Liu, Jiaan [5 ]
Xie, Juan [2 ]
Tian, Ye [3 ]
Lei, Qiancheng [1 ]
Chen, Rui [1 ]
Sun, Ming [3 ]
Tang, Lei [1 ]
Gong, Guowei [4 ]
Zhao, Yanfang [3 ]
机构
[1] Guizhou Med Univ, Guizhou Prov Engn Technol Res Ctr Chem Drug R&D, State Key Lab Funct & Applicat Med Plants, Guiyang 550004, Peoples R China
[2] Guizhou Prov Peoples Hosp, Dept Pharm, Guiyang 550002, Peoples R China
[3] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Peoples R China
[4] Zunyi Med Univ, Dept Bioengn, Zhuhai Campus, Zhuhai 519041, Guangdong, Peoples R China
[5] Univ Massachusetts Amherst, Dept Chem, Amherst, MA 01003 USA
基金
中国国家自然科学基金;
关键词
PI3K alpha; Antiproliferative activities; Synthesis; 2,3,4,5-Tetra-substituted thiophene derivatives; PI3K INHIBITORS; DISCOVERY; PATHWAY; NVP-BYL719; TARGET;
D O I
10.1016/j.ejmech.2020.112309
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using a rational design strategy for isoform-selective inhibition of PI3K alpha, two series of novel 2,3,4,5-tetra-substituted thiophene derivatives containing either diaryl urea or N-Acylarylhydrazone scaffold were designed and synthesized. The most promising compound 12k was demonstrated to bear nanomolar PI3K alpha inhibitory potency with 12, 28, 30, 196-fold selectivity against isoforms beta, gamma, delta and mTOR. Besides, it also showed good developability profiles in cell-based proliferation against a panel of human tumor cells as well as ADME assays. We herein report on their design, synthesis, SAR and potential developability properties. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss
    Xu, Shan
    Luo, Leixuan
    Sun, Xin
    Yang, Yang
    Guo, Qiuyan
    Jiang, Zhiyan
    Wu, Yingliang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 78
  • [2] Synthesis and Biological Activity of Novel PI3K/mTOR Inhibitors
    Wang Lei
    Zheng Guojun
    Ji Qi
    Chen Bo
    Gong Longlong
    Gao Congmin
    Du Zhenjian
    Zhang Xingmin
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2017, 38 (09): : 1590 - 1595
  • [3] Design, synthesis and antitumor effects of novel benzimidazole derivatives as PI3K inhibitors
    Wu, Wenping
    Li, Sisi
    Chen, Junjie
    Duo, Tena
    Ma, Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 95
  • [4] Synthesis and antitumor activity evaluation of 4,6-disubstituted quinazoline derivatives as novel PI3K inhibitors
    Hei, Yuan-Yuan
    Xin, Minhang
    Zhang, Hao
    Xie, Xiao-Xiao
    Mao, Shuai
    Zhang, San-Qi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (18) : 4408 - 4413
  • [5] Synthesis and biological activity of Akt/PI3K inhibitors
    Redaelli, C.
    Granucci, F.
    De Gioia, L.
    Cipolla, L.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (10) : 1127 - 1136
  • [6] Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors
    Yu, Lide
    Wang, Qinqin
    Wang, Caolin
    Zhang, Binliang
    Yang, Zunhua
    Fang, Yuanying
    Zhu, Wufu
    Zheng, Pengwu
    MOLECULES, 2019, 24 (19):
  • [7] Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors
    Saurat, Thibault
    Buron, Frederic
    Rodrigues, Nuno
    de Tauzia, Marie-Ludivine
    Colliandre, Lionel
    Bourg, Stephane
    Bonnet, Pascal
    Guillaumet, Gerald
    Akssira, Mohamed
    Corlu, Anne
    Guillouzo, Christiane
    Berthier, Pauline
    Rio, Pascale
    Jourdan, Marie-Lise
    Benedetti, Helene
    Routier, Sylvain
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (03) : 613 - 631
  • [8] Discovery of cinnoline derivatives as potent PI3K inhibitors with antiproliferative activity
    Tian, Chengze
    Yang, Chengbin
    Wu, Tianze
    Lu, Mingzhu
    Chen, Yi
    Yang, Yongtai
    Liu, Xiaofeng
    Ling, Yun
    Deng, Mingli
    Jia, Yu
    Zhou, Yaming
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 48
  • [9] Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity
    Liu, Kevin K-C.
    Zhu, JinJiang
    Smith, Graham L.
    Yin, Min-Jean
    Bailey, Simon
    Chen, Jeffrey H.
    Hu, Qiyue
    Huang, Qinhua
    Li, Chunze
    Li, Qing J.
    Marx, Matthew A.
    Paderes, Genevieve
    Richardson, Paul F.
    Sach, Neal W.
    Walls, Marlena
    Wells, Peter A.
    Zou, Aihua
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (11): : 809 - 813
  • [10] Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors
    Ma, Chen-Chen
    Liu, Zhao-Peng
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (03) : 395 - 403